Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.9600
-0.0500 (-4.95%)
Jun 13, 2025, 4:00 PM - Market closed
Estrella Immunopharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Estrella Immunopharma stock has a target of 16, which predicts a 1,566.67% increase from the current stock price of 0.96.
Price Target: $16.00 (+1,566.67%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Estrella Immunopharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +1,566.67% | Jun 3, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +1,566.67% | May 29, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +1,566.67% | Feb 21, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +1,566.67% | Feb 18, 2025 |
Financial Forecast
Revenue This Year
1.02B
from 506.75M
Increased by 101.09%
Revenue Next Year
n/a
from 1.02B
EPS This Year
-0.47
from -0.24
EPS Next Year
-0.77
from -0.47
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | |||
| Avg | n/a | n/a | n/a | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.48 | -0.79 | -0.98 | |||
| Avg | -0.47 | -0.77 | -0.95 | |||
| Low | -0.45 | -0.74 | -0.91 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.